Nanoliposomal irinotecan in combination with leucovorin and 5‑fluorouracil in advanced biliary tract cancers-Reference-Cited by-同舟云学术

Nanoliposomal irinotecan in combination with leucovorin and 5‑fluorouracil in advanced biliary tract cancers

Published:2021-12-24 Issue:2 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Allo Gabriel¹,Can Ahu¹,Wahba Roger²,Vogel Nils¹,Goeser Tobias¹,Kütting Fabian¹,Waldschmidt Dirk¹

Affiliation:

1. Department for Gastroenterology and Hepatology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, D-50937 Cologne, Germany

2. Department of General, Visceral and Cancer and Transplant Surgery, University Hospital of Cologne, University of Cologne, D-50937 Cologne, Germany

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Metastatic Biliary Cancers With Irinotecan and 5-Fluorouracil Based Chemotherapy After Platinum/Gemcitabine Progression: A Systematic Review and Meta-Analysis;Clinical Colorectal Cancer;2024-06

2. Treatment options for biliary tract cancer: unmet needs, new targets and opportunities from both physicians' and patients' perspectives;Future Oncology;2024-05-30

3. Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials;Clinical Oncology;2024-02

4. Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma;The Oncologist;2023-06-20

5. Nanoparticle-mediated therapeutic management in cholangiocarcinoma drug targeting: Current progress and future prospects;Biomedicine & Pharmacotherapy;2023-02